1)   

1)     Approval from the ethics committee will be obtained before conducting the study.

2)      KAP questionnaire & Subject Information Leaflet (PIL) will be prepared by referring to various primary, secondary, and tertiary sources.

3)      Prepared SIL(Subject Information Leaflet) will be validated for its content and design using various readability statistics (Western formula) and user readability testing.

4)      User testing questionnaires will be developed based on the content of the SILS and will also be validated.

5)      The validated KAP questionnaires will be used to identify the Knowledge ,Attitude and perception of Community pharmacist, Students and Patients.

6)      The Community pharmacist, Students, Patients will be enrolled in the study after obtaining written informed consent .

7)      All the relevant information will be collected in a specially designed data collection.

8)      The Community Pharmacist , Students and patients  will be assessed for the knowledge, Attitude and Perception level  using pre-validated tools.

9)      The enrolled Community Pharmacist after screening them and obtaining Informed Consent they will be administering  KAP questionnaires as pre test to assess knowledge Attitude and Perception.

10)    The Community Pharmacist will be requesting to attend Webinar and educational intervention by a clinical pharmacist. (Educational intervention includes the additional Information offered by the Clinical Pharmacist about Topical Corticosteroid. The pharmacist will analyse the Knowledge level from the Pre-test conducted by using KAP Questionnaires and will provide the Pharmacist education and counselling on various aspects of Topical Corticosteroids , including potency of topical corticosteroids and its common side effects, need for adherence to drug therapy. The student will be provided with the validated SIL(Subject Information Sheet), after one month followup will be taken using same KAP Questionnaires by electronic means)

11)  The enrolled Students will be randomly assigned to the two groups viz-intervention group (IG) and the Control group (CG).

12)  The Control group will receive Student Information Leaflet without Counselling  by the Clinical Pharmacist.

13)  The intervention group will receive the Counselling by the physician via Webinar and educational intervention by a clinical pharmacist. (Educational intervention includes the additional care offered by the Clinical Pharmacist. The pharmacist will analyse the Student drug therapy if any, and will provide the Student education and counselling on various aspects of Topical Corticosteroids , including diseases, drugs and its common side effects, need for adherence to drug therapy, and need and measures for lifestyle modification. The student will be provided with the validated SIL, monthly reminder regarding the drug therapy by electronic means if any)

14)  All the enrolled students in both of the groups will be called on follow up, and the responses on the knowledge level, Attitude, and perception about Topical Corticosteroids of the Students will be recorded. (A total of three times KAP Questionnaire will be administered  , i.e., baseline, after 1^st month  and 3^rd month .

15)  The enrolled Patients after screening them and obtaining Informed Consent they will be administering  KAP questionnaires as pre test to assess knowledge , Attitude and Perception about Topical Corticosteroids.